SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 25.37-1.3%1:35 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Oak Tree who wrote (14008)7/6/2000 10:26:51 AM
From: Bluegreen  Read Replies (1) of 17367
 
You stated>>>>>>>>By this argument, low levels of BPI might be bad and high levels good -- hence the need for 15x or higher. Even however if this is true, it supports my previous statements. This drug is hard to use safely and effectively, the moon and stars have to be in the correct orbit. This is not a robust reliable antimicrobial therapy.<<<<<<
Maybe you should let Allergan and Baxter in on your opinions????LOL These are just your OPINIONS aren't they??? One thing about this board is that we always try to back up our opinions with something other than shear imagination and wild speculation. I have no problem with anyone bashing XOMA just as long as opinions are backed up with something of substance. Ask yourself why both Baxter and Allergan are involved in a product that has the possible scenario you stated supra. BTW, XOMA already has patents on modified LBP. Why is that modified LBP important????
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext